Human Celiac PBMC |
ABC-TC4379 |
AcceGen |
1 vial |
Ask for price |
|
Description: Celiac disease (CD) is a systemic disorder characterized by an immune-mediated reaction to gluten and a wide spectrum of clinical manifestations. Human Celiac PBMC are isolated from human donors with Celiac Disease using a density gradient centrifugation method for purification. |
Iga Antibody Laboratories manufactures the iga antibiody in celiac reagents distributed by Genprice. The Iga Antibiody In Celiac reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other Iga products are available in stock. Specificity: Iga Category: Antibiody Group: In Celiac
Single Donor Human Celiac Plasma |
Innovative research |
each |
EUR 209 |
|
Description: Single Donor Human Celiac Plasma |
Single Donor Human Celiac Serum |
MyBiosource |
INQUIRE |
Ask for price |
Single Donor Human Celiac Plasma |
MyBiosource |
INQUIRE |
Ask for price |
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
In Celiac information
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6254474-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6254474-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6251448-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6251448-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6268347-01mL |
MyBiosource |
0.1mL |
EUR 995 |
CD152 (CD152 Antigen, Celiac Disease 3, CELIAC3, Cytotoxic T cell associated 4, Cytotoxic T-lymphocyte-associated Antigen 4, CTLA 4, CTLA4, CTLA-4, Cytotoxic T-lymphocyte-associated Protein 4, Cytotoxic T-lymphocyte-associated Serine Esterase 4, Cytotoxic |
MBS6268347-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
CELIAC2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K0430905 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
CELIAC2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K0430906 |
ABM |
1.0 ug DNA |
EUR 200.4 |
CELIAC2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K0430907 |
ABM |
1.0 ug DNA |
EUR 200.4 |
CELIAC2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K0430908 |
ABM |
1.0 ug DNA |
EUR 200.4 |
anti-human IgA-Purified (with Antibiotics) |
MBS666379-01mg |
MyBiosource |
0.1mg |
EUR 360 |
anti-human IgA-Purified (with Antibiotics) |
MBS666379-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1480 |
CELIAC2 3'UTR GFP Stable Cell Line |
TU054206 |
ABM |
1.0 ml |
EUR 2799.6 |
CELIAC2 ORF Vector (Human) (pORF) |
ORF017235 |
ABM |
1.0 ug DNA |
Ask for price |
CELIAC2 3'UTR Luciferase Stable Cell Line |
TU004206 |
ABM |
1.0 ml |
EUR 2799.6 |
CELIAC2 Protein Vector (Human) (pPM-C-HA) |
PV068939 |
ABM |
500 ng |
Ask for price |
CELIAC2 Recombinant Protein (Human) |
RP051703 |
ABM |
100 ug |
Ask for price |